Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0376 USD | -5.16% | -5.28% | +6.50% |
Mar. 28 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | 16.2M | Sales 2023 | 16M | Capitalization | 5.47M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | 3M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K | Net cash position 2023 | 875K | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | 43 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CV Sciences, Inc.
1 day | -5.16% | ||
1 week | -5.28% | ||
Current month | -8.05% | ||
1 month | -3.33% | ||
3 months | +1.07% | ||
6 months | -0.79% | ||
Current year | +6.50% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 14-06-15 | |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.0376 | -5.16% | 79,205 |
24-04-25 | 0.0397 | 0.00% | 46,553 |
24-04-24 | 0.0397 | +4.61% | 92,028 |
24-04-23 | 0.038 | 0.00% | 80,457 |
24-04-22 | 0.038 | -4.65% | 130,784 |
Delayed Quote OTC Markets, April 26, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+6.50% | 6.15M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CVSI Stock